George S. May Business Blog

Google Ventures set put $10 million into biotech

Google is said to be putting their venture capital fund, Google Ventures, to use as reports circulate that they are getting set to put an estimated $10 million into Adimab, a biotech firm.

Adimab has been “hot” in the biotech world for developing a new method for generating protein-based drugs. Adimab has already struck deals with drug-makers Merck (MRK) and Roche (RHHBY).

Before the Adimab deal, Google Ventures was yet to invest in the biotech world. Prior to the creation of Google Ventures, however, Google itself had.

Google Ventures is the lead investor in a round said to have raised about $15 million.

Related posts:

1. Verizon getting Google’s Nexus One If AT&T wasn’t getting nervous before, they may be now. Google has agreed to bring its Nexus One phone to Verizon. In the press release,...


2. Seeking Alpha pulls in $7 million in their second round of funding Financial information and analysis website, Seeking Alpha, has managed to raise $7 million in their second round of funding, PaidContent reports. The leading investor was...


3. Twitter to raise $100 million Word on the street is that Twitter, the uber popular, social-networking phenomenon, is about to come into a whole lot of cash. Between investments from...


4. Chegg.com rakes in $57 million for textbook rental site Recession? Slouching economy? I bet Chegg.com would tell you differently. “Chegg.com, an online textbook-rental company, said it has raised $57 million in venture capital, in...


5. Serious Materials grabs another $60 million for Green Building Materials The green-building materials company, Serious Materials, announced today that it raised $60 million in its third round of funding, representing one of the largest US...